Food and Drug Administration

Condividi contenuti
Aggiornato: 36 min 31 sec fa

FDA Roundup: July 5, 2022

Ma, 05/07/2022 - 22:17
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Roundup: July 1, 2022

Ve, 01/07/2022 - 17:53
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Infant Formula Update: June 30, 2022

Gi, 30/06/2022 - 19:36
FDA Infant Formula Update June 30 Danone New Zealand
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Recommends Inclusion of Omicron BA.4/5 Component for COVID-19 Vaccine Booster Doses

Gi, 30/06/2022 - 16:05
The FDA has advised manufacturers seeking to update their COVID-19 vaccines that they should develop modified vaccines that add an omicron BA.4/5 spike protein component to the current vaccine composition to create a two component (bivalent) booster vaccine, beginning in Fall 2022.
Categorie: Istituzioni

FDA Roundup: June 28, 2022

Ma, 28/06/2022 - 20:37
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Infant Formula Update: June 28, 2022

Ma, 28/06/2022 - 20:06
FDA Infant Formula Update June 28 Abbott (Ireland)
Categorie: Istituzioni

FDA Introduces Innovative Proposal to Advance Consumer Access to Nonprescription Drugs

Lu, 27/06/2022 - 16:12
Today, the FDA issued a proposal to broaden the range of marketed nonprescription drugs available to consumers.
Categorie: Istituzioni

FDA Infant Formula Update: June 27, 2022

Lu, 27/06/2022 - 15:14
FDA Infant Formula Update June 27 Bellamy (Australia)
Categorie: Istituzioni

FDA Roundup: June 24, 2022

Ve, 24/06/2022 - 21:53
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Releases Action Plan for Rare Neurodegenerative Diseases, Including ALS

Gi, 23/06/2022 - 17:37
The FDA launched the Action Plan for Rare Neurodegenerative Diseases including ALS, outlining the agency’s strategy for improving and extending the lives of people living with these diseases by advancing the development of safe, effective medical products, and by facilitating patient access to novel
Categorie: Istituzioni

FDA Denies Authorization to Market JUUL Products

Gi, 23/06/2022 - 16:27
Today, the U.S. Food and Drug Administration issued marketing denial orders (MDOs) to JUUL Labs Inc. for all of their products currently marketed in the United States. As a result, the company must stop selling and distributing these products.
Categorie: Istituzioni

FDA Infant Formula Update: June 22, 2022

Me, 22/06/2022 - 21:30
FDA exercises enforcement discretion to Global Kosher to import various Kendamil infant formula products from United Kingdom following review of nutritional adequacy and safety information, including microbiological testing, labeling, facility production and inspection history
Categorie: Istituzioni

FDA Provides Update on Efforts to Increase Supply and Availability of Safe and Nutritious Infant Formula

Me, 22/06/2022 - 20:35
FDA is providing an update on steps it has taken and will take to ensure safe and nutritious infant formula
Categorie: Istituzioni

FDA Announces Plans for Proposed Rule to Reduce Addictiveness of Cigarettes and Other Combusted Tobacco Products

Me, 22/06/2022 - 00:30
The Biden-Harris Administration published plans for future potential regulatory actions that include the FDA’s plans to develop a proposed product standard that would establish a maximum nicotine level to reduce the addictiveness of cigarettes and certain other combusted tobacco products.
Categorie: Istituzioni

FDA Roundup: June 21, 2022

Ma, 21/06/2022 - 20:56
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

FDA Infant Formula Update: June 17, 2022

Ve, 17/06/2022 - 23:51
FDA exercises enforcement discretion to Danone to import Aptamil infant formula products from Ireland following review of nutritional adequacy and safety information, including microbiological testing, labeling, facility production and inspection history.
Categorie: Istituzioni

FDA Roundup: June 17, 2022

Ve, 17/06/2022 - 22:09
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni

Coronavirus (COVID-19) Update: FDA Authorizes Moderna and Pfizer-BioNTech COVID-19 Vaccines for Children Down to 6 Months of Age

Ve, 17/06/2022 - 14:52
The FDA authorized emergency use of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include use in children down to 6 months of age.
Categorie: Istituzioni

FDA Infant Formula Update: June 15, 2022

Me, 15/06/2022 - 21:27
FDA exercises enforcement discretion to Mead Johnson Nutrition/Reckitt to import Enfamil Stage 1 infant formula products from Singapore following review of nutritional adequacy and safety information, including microbiological testing, labeling, facility production and inspection history.
Categorie: Istituzioni

FDA Roundup: June 14, 2022

Ma, 14/06/2022 - 19:15
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Categorie: Istituzioni